HCA FLORIDA TRINITY HOSPITAL
9330 SR 54, TRINITY, FL · HCA Florida Healthcare · · NPI 1891741849
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $5,566,309.64 – $5,566,309.64 | 1 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $27.88 – $58.63 | 3 |
| Inj, palonosetron (posfrea) HCPCS J2468 | $3,000.47 | $3,000.47 | $58.11 – $125.95 | 3 |
| Inj pantoprazole(hikma) 40mg HCPCS J2471 | $82.67 | $82.67 | $8.13 – $8.13 | 1 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $68.32 – $153.12 | 3 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $511.13 – $1,236.40 | 3 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $96.07 – $214.94 | 3 |
| Inj, pedmark, 100 mg HCPCS J0208 | $621.00 | $621.00 | $206.55 – $206.55 | 1 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $139.67 – $296.81 | 3 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $23.97 – $256.47 | 3 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $80.65 – $80.65 | 1 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $44.96 – $85.85 | 3 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.45 – $20.94 | 3 |
| Inj, pemetrexed (avyxa) 10mg HCPCS J9292 | not published | not published | $174.64 – $174.64 | 1 |
| Inj pemetrexed (bluepoint) HCPCS J9322 | not published | not published | $22.79 – $22.79 | 1 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $0.28 – $10.34 | 3 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $3.74 – $9.01 | 3 |
| Inj pemetrexed (sandoz) 10mg HCPCS J9297 | not published | not published | $1.69 – $3.20 | 3 |
| Inj pemetrexed (teva) 10mg HCPCS J9314 | not published | not published | $8.12 – $32.96 | 3 |
| Inj, pemivibart, 4500 mg HCPCS Q0224 | not published | not published | $6,385.99 – $15,563.85 | 3 |
| Inj, pemrydi rtu, 10 mg HCPCS J9324 | not published | not published | $78.63 – $157.64 | 3 |
| Inj peritoneal venous shunt CPT 49427 | not published | not published | $5,322.84 – $5,434.90 | 3 |
| Inj., perseris, 0.5 mg HCPCS J2798 | not published | not published | $11.79 – $26.10 | 3 |
| Inj plasminogen tvmh 1mg HCPCS J2998 | not published | not published | $74.50 – $74.50 | 1 |
| Inj., plazomicin, 5 mg HCPCS J0291 | not published | not published | $3.46 – $7.55 | 3 |
| Inj pozelimab-bbfg, 1 mg HCPCS J9376 | not published | not published | $197.22 – $197.22 | 1 |
| Inj proc ankle arthr CPT 27648 | not published | not published | $194.94 – $199.04 | 3 |
| Inj proc elbow arthro CPT 24220 | not published | not published | $323.60 – $330.41 | 3 |
| Inj proc for lymphang CPT 38790 | not published | not published | $5,805.32 – $5,927.53 | 3 |
| Inj proc lumbr disk ea lvl CPT 62290 | not published | not published | $1,407.46 – $1,437.09 | 3 |
| Inj proc myelogram lumbar CPT 62284 | not published | not published | $828.50 – $845.94 | 3 |
| Inj proc sialogram CPT 42550 | not published | not published | $7.80 – $7.96 | 3 |
| Inj progesterone per 50 mg HCPCS J2675 | $52.40 | $52.40 | $0.64 – $1.55 | 3 |
| Inj prohance multipack HCPCS A9576 | not published | not published | $1.39 – $3.05 | 3 |
| Inj recombin esperoct per iu HCPCS J7204 | not published | not published | $2.08 – $4.82 | 3 |
| Inj, releuko 1 mcg HCPCS Q5125 | not published | not published | $0.42 – $0.73 | 3 |
| Inj retacrit esrd on dialysi HCPCS Q5105 | not published | not published | $0.69 – $1.63 | 3 |
| Inj retro urethrocysto CPT 51610 | not published | not published | $665.72 – $679.74 | 3 |
| Inj, rimabotulinumtoxinb HCPCS J0587 | not published | not published | $12.61 – $28.57 | 3 |
| Inj roctavian ml 2x10^13vc g HCPCS J1412 | not published | not published | $26,990.48 – $26,990.48 | 1 |
| Inj romidepsin non-lyo 0.1mg HCPCS J9318 | not published | not published | $61.32 – $61.32 | 1 |
| Inj, rykindo, 0.5 mg HCPCS J2801 | not published | not published | $28.01 – $28.01 | 1 |
| Inj scleros sol mult veins CPT 36471 | not published | not published | $2,572.23 – $2,626.38 | 3 |
| Inj scleros sol sgl vein CPT 36470 | not published | not published | $2,572.23 – $2,626.38 | 3 |
| Inj, sculptra, 0.5mg HCPCS Q2028 | not published | not published | $4.64 – $4.64 | 1 |
| Inj sebelipase alfa 1 mg HCPCS J2840 | not published | not published | $1,161.17 – $1,161.17 | 1 |
| Inj secretin synthetic human HCPCS J2850 | not published | not published | $86.95 – $86.95 | 1 |
| Inj secukinumab intrav 1mg HCPCS J3247 | not published | not published | $17.20 – $38.85 | 3 |
| Inj, sezaby, 1 mg HCPCS J2561 | not published | not published | $2.54 – $2.54 | 1 |
| Inj, spesolimab-sbzo, 1 mg HCPCS J1747 | not published | not published | $59.59 – $141.32 | 3 |
| Inj(s) sclerosant spider veins limb/trunk CPT 36468 | not published | not published | $2,572.23 – $2,626.38 | 3 |
| Inj sulf hexa lipid microsph HCPCS Q9950 | not published | not published | $18.16 – $39.07 | 3 |
| Inj, susvimo 0.1 mg HCPCS J2779 | not published | not published | $77.35 – $163.87 | 3 |
| Inj, sutimlimab-jome, 10 mg HCPCS J1302 | not published | not published | $17.59 – $40.91 | 3 |
| Inj. tagraxofusp-erzs 10 mcg HCPCS J9269 | not published | not published | $328.37 – $767.59 | 3 |
| Inj, taliglucerace alfa 10 u HCPCS J3060 | not published | not published | $39.42 – $88.02 | 3 |
| Inj teclistamab cqyv 0.5 mg HCPCS J9380 | not published | not published | $31.45 – $74.35 | 3 |
| Inj tedizolid phosphate HCPCS J3090 | not published | not published | $1.75 – $4.21 | 3 |
| Inj teplizumab mzwv 5 mcg HCPCS J9381 | not published | not published | $36.19 – $82.54 | 3 |
| Inj. teprotumumab-trbw 10 mg HCPCS J3241 | not published | not published | $341.98 – $794.02 | 3 |
| Inj testostero enanthate 1mg HCPCS J3121 | not published | not published | $0.05 – $0.11 | 3 |
| Inj, testosterone, azmiro HCPCS J1072 | not published | not published | $2.86 – $2.86 | 1 |
| Inj testosterone cypionate HCPCS J1071 | $1.62 | $1.62 | $0.03 – $0.06 | 3 |
| Inj thiotepa nos 1 mg HCPCS J9342 | not published | not published | $19.05 – $19.05 | 1 |
| Inj., tildrakizumab, 1 mg HCPCS J3245 | not published | not published | $127.52 – $266.15 | 3 |
| Inj, tislelizumab-jsgr HCPCS J9329 | not published | not published | $125.50 – $125.50 | 1 |
| Inj tofersen intrathec 1 mg HCPCS J1304 | not published | not published | $150.68 – $344.02 | 3 |
| Inj, tofidence, 1 mg HCPCS Q5133 | not published | not published | $5.79 – $12.02 | 3 |
| Inj travoprost intra impl HCPCS J7355 | not published | not published | $188.58 – $421.89 | 3 |
| Inj triamcinolone ace X-ray 1mg HCPCS J3304 | not published | not published | $17.47 – $39.95 | 3 |
| Inj., triluron, 1 mg HCPCS J7332 | not published | not published | $9.97 – $21.76 | 3 |
| Inj., triptorelin X-ray 3.75 mg HCPCS J3316 | not published | not published | $3,400.86 – $8,094.73 | 3 |
| Inj, trivisc 1 mg HCPCS J7329 | not published | not published | $5.42 – $7.76 | 3 |
| Inj, tyenne, 1 mg HCPCS Q5135 | not published | not published | $3.95 – $9.01 | 3 |
| Inj ustekinumab-aekn, 1 mg HCPCS Q9998 | not published | not published | $92.88 – $92.88 | 1 |
| Inj ustekinumab-kfce, 1 mg HCPCS Q5100 | not published | not published | $53.06 – $53.06 | 1 |
| Inj ustekinumab-stba, 1 mg HCPCS Q5099 | not published | not published | $25.48 – $25.48 | 1 |
| Inj, uzedy, 1 mg HCPCS J2799 | not published | not published | $23.88 – $53.84 | 3 |
| Inj, vancomycin hcl (mylan) HCPCS J3371 | not published | not published | $6.12 – $6.31 | 2 |
| Inj, vancomycin hcl (xellia) HCPCS J3372 | not published | not published | $6.34 – $6.54 | 2 |
| Inj vancomycin (xellia) 10mg HCPCS J3375 | not published | not published | $0.28 – $0.28 | 1 |
| Inj vasopressin (am reg) 1 u HCPCS J2599 | not published | not published | $1.29 – $1.85 | 3 |
| Inj, vasopressin (baxter) HCPCS J2601 | not published | not published | $3.40 – $4.77 | 3 |
| Inj, vegzelma, 10 mg HCPCS Q5129 | not published | not published | $46.64 – $82.04 | 3 |
| Inj velmanase alfa-tycv 1 mg HCPCS J0217 | not published | not published | $431.63 – $1,000.24 | 3 |
| Inj., vestronidase alfa-vjbk HCPCS J3397 | not published | not published | $602.19 – $602.19 | 1 |
| Inj. viltolarsen HCPCS J1427 | not published | not published | $145.51 – $145.51 | 1 |
| Inj vocal cord bulking agent HCPCS L8607 | not published | not published | $51.53 – $77.02 | 28 |
| Inj w/fluor eval cv device CPT 36598 | not published | not published | $2,274.95 – $2,322.84 | 3 |
| Inj. xembify, 100 mg HCPCS J1558 | not published | not published | $13.85 – $32.38 | 3 |
| Inj xipere 1 mg HCPCS J3299 | not published | not published | $46.78 – $102.88 | 3 |
| Inj., yutiq, 0.01 mg HCPCS J7314 | not published | not published | $508.83 – $1,139.26 | 3 |
| Inj zanidatamab-hrii, 2 mg HCPCS J9276 | not published | not published | $53.75 – $53.75 | 1 |
| Inj zenocutuzumab-zbco 1 mg HCPCS J9382 | not published | not published | $72.18 – $72.18 | 1 |
| Inner skull vessel surgery CPT 61702 | not published | not published | $184.21 – $188.09 | 3 |
| Inotuzumab ozogamicin 0.9 mg(0.25 mg/ml initial concentration) IV soln HCPCS J9229 | not published | not published | $2,578.39 – $6,056.06 | 3 |
| Inpatient consultation CPT 99251 | not published | not published | $54.15 – $55.29 | 3 |
| Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy HCPCS G0459 | not published | not published | $44.65 – $45.59 | 3 |
| Inpt/ed teleconsult30 HCPCS G0425 | not published | not published | $106.40 – $108.64 | 3 |
| Inpt/ed teleconsult50 HCPCS G0426 | not published | not published | $144.40 – $147.44 | 3 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.